Showing results (241-250 of 560) with videos related to
Sort By:
Pageof 56
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 14, 2012
Congenital FVII deficiency and pulmonary embolism: a critical appraisal of all reported casesA Girolami, G Berti de Marinis, S Vettore, et al.Blood|July 1, 1979
Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary patternA Girolami, G Cattarozzi, R Dal Bo Zanon, et al.Blut|August 1, 1983
Antithrombin III (AT III) Padua2: a "new" congenital abnormality with defective heparin co-factor activities but no thrombotic diseaseA Girolami, F Fabris, G Cappellato, et al.Endocrine-Related Cancer|April 8, 2006
Clinical trials with retinoids for breast cancer chemopreventionS Zanardi, D Serrano, A Argusti, et al.Cancer Letters|December 1, 1986
Fibronectin concentration in the plasma of patients with malignant and benign breast diseaseF Boccardo, D Guarneri, S Zanardi, et al.Plant Biology (Stuttgart, Germany)|September 6, 2021
Structural and histochemical attributes of secretory ducts and cavities in leaves of four species of Calophyllaceae J. Agardh in Amazonian savannasM J G Pessoa, S Pireda, P Simioni, et al.Journal of Thrombosis and Haemostasis : JTH|January 22, 2010
Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individualsL F A Maurissen, E Castoldi, P Simioni, et al.Thrombosis and Haemostasis|January 30, 2018
Contact System Activation and Cancer: New Insights in the Pathophysiology of Cancer-Associated ThrombosisE Campello, M W Henderson, D F Noubouossie, et al.Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|December 28, 2013
Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patientsA Girolami, L Sambado, E Bonamigo, et al.Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1986
Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patientsM Vicarioto, A Rosolen, M G Cappellato, et al.Pageof 56